Epstein Becker Green (EBG) provided regulatory counsel to a private equity firm investing in a multinational provider of pre-clinical and clinical research, laboratory testing, and consulting services to the medical device industry. EBG performed a regulatory due diligence review of the target’s compliance with requirements of the FDA, U.S. Department of Agriculture, and other regulatory authorities.
People
- Board of Directors / Member of the Firm
- Member of the Firm
- Senior Counsel
- Member of the Firm